Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Pidilizumab (Primary) ; Dendritic cell vaccines
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 30 Jun 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2019.
- 09 Dec 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.
- 09 Dec 2016 Status changed from recruiting to active, no longer recruiting.